AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. SPY
8. XYZ
9. ANET
10. CVS

Go back to AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance

AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance

April 7, 2022 7:00 AM EDT

Fiscal 2022 Third Quarter Highlights

Net sales of $74.0 million increased 3.9% compared to the prior-year quarter Med Tech grew 28.6% and Med Device declined 2.8% year over year Gross margin of 52.2% declined 190 basis points year over year GAAP loss per share of $0.13 and adjusted earnings per share of $0.03 Subsequent to quarter end: the Company enrolled the first patients in its PRESERVE study for the use of NanoKnife in prostate; the Company received FDA approval for its... More